相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate
Ryan B. Gil et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Puromycin aminonucleoside triggers apoptosis in podocytes by inducing endoplasmic reticulum stress
Seo-Yoon Min et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2018)
Beneficial Effects of Myo-Inositol Oxygenase Deficiency in Cisplatin-Induced AKI
Rajesh K. Dutta et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population
Peggy Sekula et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Blood, urine and faecal metabolite profiles in the study of adult renal disease
Clara Barrios et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2016)
Systematic biomarker discovery and coordinative validation for different primary nephrotic syndromes using gas chromatography-mass spectrometry
Jung-Eun Lee et al.
JOURNAL OF CHROMATOGRAPHY A (2016)
Minimal change disease and idiopathic FSGS: manifestations of the same disease
Rutger J. Maas et al.
NATURE REVIEWS NEPHROLOGY (2016)
The role of local IL6/JAK2/STAT3 signaling in high glucose-induced podocyte hypertrophy
Hyung Ah Jo et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2016)
A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
Joann M. Spinale et al.
KIDNEY INTERNATIONAL (2015)
Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study
Monika A. Niewczas et al.
KIDNEY INTERNATIONAL (2014)
Assessing the Metabolic Effects of Calcineurin Inhibitors in Renal Transplant Recipients by Urine Metabolic Profiling
Binta Dieme et al.
TRANSPLANTATION (2014)
Potential role and therapeutic interests of myo-inositol in metabolic diseases
Marine L. Croze et al.
BIOCHIMIE (2013)
The Treatment of Minimal Change Disease in Adults
Jonathan Hogan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Distinct Metabolic Profile of Primary Focal Segmental Glomerulosclerosis Revealed by NMR-Based Metabolomics
Xu Hao et al.
PLOS ONE (2013)
Urine But Not Serum Soluble Urokinase Receptor (suPAR) May Identify Cases of Recurrent FSGS in Kidney Transplant Candidates
Carlos R. Franco Palacios et al.
TRANSPLANTATION (2013)
Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum
Xianfu Gao et al.
BMC SYSTEMS BIOLOGY (2012)
A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy
Weiguo Sui et al.
CLINICS (2012)
Circulating suPAR in Two Cohorts of Primary FSGS
Changli Wei et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysis
Ji-Young Choi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis
Lindsey E. Romick-Rosendale et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Changing incidence of glomerular disease in Olmsted County, Minnesota: A 30-year renal biopsy study
Sundararaman Swaminathan et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Focal segmental glomerulosclerosis in nephrotic adults: Presentation, prognosis, and response to therapy of the histologic variants
MJ Chun et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Glomerular tip lesion: A distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum
MB Stokes et al.
KIDNEY INTERNATIONAL (2004)
分享论文
